Navigation Links
Scottish Scientists Lead This Year's Life Science Discoveries
Date:4/23/2013

CHICAGO, April 23, 2013 /PRNewswire/ -- Since January, Scotland has announced significant progress on several major life science discoveries slated to treat life-threatening diseases such as cancer, HIV and leukemia.

Scotland offers the UK's fastest R&D approval times and already ranks as the leading UK region for R&D investment, according to data from Ernst & Young. With industry challenges on the rise, Scotland continues to rely on its renowned R&D capabilities to generate sector growth.

To showcase their latest discoveries, 20 of Scotland's leading life science companies and research organizations are accompanying Scottish Development International, the country's economic development agency, at the 2013 BIO International Convention, April 22-25.

"Scotland continues to attract major investments from some of the world's leading life sciences companies including GlaxoSmithKline and LifeScan, further strengthening Scotland's position as a key cluster for life sciences innovation," notes Danny Cusick , President, Americas, of Scottish Development International.

Today, Scotland's BioOutsource, a global leader in the biological analysis of biosimilar molecules for the biopharmaceutical industry, announced its first facility opening in the U.S. To be based in Cambridge, Massachusetts the company believes the expansion will link Scotland's strong life science services to Boston's growing venture capital landscape.

In February, the University of Dundee and incubator campus, BioCity Scotland, won a project worth $128 million to discover new drug treatments—marking the biggest investment of its kind in Scotland from the European Innovative Medicines Initiative.

One month later, Dundee Cancer Center announced a new way to kill cancer cells in people with one of the most common forms of leukemia. Another Scottish company transforming the future treatment of cancer is VIRTTU, the first company allowed by the FDA to trial an oncolytic therapy in children, who has announced plans to assist in an upcoming pediatric brain tumor trial led by Cincinnati Children's Hospital.

Other Scottish organizations making developments include the University of Aberdeen, which was awarded $2 million in funding this February to research anti-cancer drugs utilizing shark immune system research and The University of Edinburgh, which received $26 million this month to research regenerative medicine for incurable conditions.

Scotland's recent R&D achievements have occurred alongside major company growth as well. Edinburgh BioQuarter, part of Europe's fastest-growing academic medical center, grew by more than a third in January alone thanks to new research tenants. Just this month, U.S. medical device company Daktari Diagnostics Inc. announced their decision to invest in Scotland to produce its latest HIV blood monitoring technology.

"Scotland's life science legacy boasts innovations such as the pioneering of stem-cell treatments to cure blindness and groundbreaking work to eradicate disease-carrying tsetse flies," says Cusick. "With this reputation for excellence, we feel confident that our recent R&D announcements will spur positive investment."

Home to 650+ life sciences organizations and more than 32,000 industry employees, Scotland seeks to target additional partnership and investment opportunities from North America to bolster their rapidly growing industry.

Media Contact: Rebecca Gehman , rgehman@aboutdci.com, 973-800-3306

Notes to Editors:

Scottish Development International (SDI) is a partnership between the Scottish Government, Scottish Enterprise and Highlands and Islands Enterprise. SDI helps overseas businesses tap into Scotland's key strengths in knowledge, high level skills, technology and innovation. SDI also works to help Scottish companies do more business overseas and to promote Scotland as a good place to live and work. Its work is guided by the Scottish Government's strategy for economic development in Scotland. www.sdi.co.uk


'/>"/>
SOURCE Scottish Development International
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Scripps Research Institute Scientists Find Antibody that Transforms Bone Marrow Stem Cells Directly into Brain Cells
2. Scientists Find Way to Fast-Track Production of Stem Cells that Show Promise in Treating AMD
3. A bright idea: Tiny injectable LEDs help neuroscientists study the brain
4. Highly lethal Ebola virus has diagnostic Achilles heel for biothreat detection, scientists say
5. NineSigma Announces Winners in $25,000 Sustainable Packaging Challenge in Conjunction With Scientists Without Borders and Partners
6. Research Team led by JCVI Scientists Uncover More Complexity and Detail in Southern African Genomic Diversity
7. Dr. Ali S. Faqi and Leading Scientists Author Ground-Breaking Toxicology Book from Elsevier
8. Scientists discover molecule that does double duty in stopping asthma attacks
9. Scientists Warn of Long Term Consequences of Budget Sequestration: BioInformatics LLC Report
10. UC Santa Barbara scientists develop a whole new way of harvesting energy from the sun
11. The Elsevier Foundation, TWAS, and OWSD Honor Early Career Women Scientists in Developing Countries at the Annual AAAS Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... 23, 2017 , ... AxioMed will be presenting its viscoelastic ... in Montego Bay, Jamaica from January 26-28th. “We’re excited to be presenting the ... experience the simplicity of the surgical technique,” said Jake Lubinski, President of AxioMed. ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... endeavors to bring to market a pioneering medical device for the treatment of ... an engagement contract with Emergo, a global regulatory consultancy that helps companies like ...
(Date:1/21/2017)... , Jan. 21, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, today presented ... compound, napabucasin, at the 2017 American Society of Clinical ... Francisco . In a Phase ... agent designed to inhibit cancer stemness pathways by targeting ...
(Date:1/20/2017)... -- http://www.Financialbuzz.com - According to ... of death worldwide. There were 8.2 million cancer related ... deaths increased gradually over time, the death rates have ... cancers continues to drive demand of biological therapies for ... Insights, Inc. cancer biological therapy market size was USD 61.3 ...
Breaking Biology Technology:
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/12/2017)... PUNE, India , January 12, 2017 A new report ... 2022," projects that the global biometric technology market is expected to generate revenue of ... Continue Reading ... Allied ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:1/11/2017)... , Jan. 11, 2017  Michael Johnson, co-founder of Visikol ... Capital Group, Inc., has been named to the elite "Forbes 30 ...  was one of 600 people in 20 fields nationwide to be ... of the 15,000 applicants were selected. ... He is currently a PhD candidate at Rutgers ...
Breaking Biology News(10 mins):